This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A summary of current and novel biomarkers and their potential stages of release in cardiogenicshock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenicshock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.
Circulation, Ahead of Print. Cardiogenicshock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenicshock.
Circulation, Volume 151, Issue 3 , Page 257-271, January 21, 2025. Advances in critical care therapies for patients with cardiogenicshock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%.
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (ECPR) in selected patients after out-of-hospital cardiac arrest (OHCA) is an established method if return of spontaneous circulation cannot be achieved.
She presented to an outside hospital after several days of malaise and feeling unwell. The VSR is what is causing the cardiogenicshock! Angiography usually reveals an absence of collateral circulation to the infarct zone. At the time of admission, her vital signs were normal. Heart rate was in the 80s.
Circulation, Volume 150, Issue Suppl_1 , Page A4118341-A4118341, November 12, 2024. Multivariate logistic and linear regression analyses were performed, adjusting for multiple patient and hospital confounders. There was a non-significant increased risk of cardiogenicshock (aOR 1.14, 95% CI 0.87 - 1.5,
Circulation: Heart Failure, Ahead of Print. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenicshock, cardiac arrest, and mechanical ventilation). of centers), 525 037 (18.3%) were admissions to ATCs (5.5% of centers), and 15 541 (0.5%) were transferred to ATCs.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Admissions to CICUs with the highest tertile of CCRx utilization had a greater burden of comorbidities, had more diagnoses of ST–elevation myocardial infarction, cardiac arrest, or cardiogenicshock, and had higher Sequential Organ Failure Assessment scores.
Author continued : STE in aVR is often due to left main coronary artery obstruction (OR 4.72), and is associated with in-hospital cardiovascular mortality (OR 5.58). Authors' commentary: Cardiogenicshock in the setting of severe aortic stenosis. Fundamentally, cardiogenicshock is an issue of decreased cardiac output.
But the lack of traditional Sgarbossa criteria is not reassuring enough for such high pretest probability (elderly patient with chest pain, out of hospital cardiac arrest and LBBB), and the Modified Sgarbossa Criteria confirms Occlusion MI in this case. But by this time the patient went into cardiogenicshock and passed away.
Circulation: Heart Failure, Ahead of Print. BACKGROUND:There are limited large-scale data on the outcomes of patients with cardiogenicshock (CS) transferred to hub centers. Overlap propensity score weighting was performed to assess the association between transfer status and in-hospital mortality.
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenicshock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% 1.09];P=0.08).CONCLUSIONS:In
Circulation, Volume 150, Issue Suppl_1 , Page A4145617-A4145617, November 12, 2024. Background:Cardiogenic shock (CS) has high morbidity and mortality rates. Among AMI-CS hospitalizations, Black patients were less likely to receive IABP (aOR: 0.87, 95%CI: 0.82-0.93), 0.93), pLVAD (aOR: 0.79, 95%CI: 0.72-0.86),
Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenicshock. Cardiogenicshock and acute ST-segment–elevation myocardial infarction are exclusions.
The patient in today’s case presented in cardiogenicshock from proximal LAD occlusion, in conjunction with a subtotally stenosed LMCA. The patient was extubated on Day-3 of the hospital stay. The patient improved, and on Day-11 of the hospital stay — he was off inotropes and on a small dose of a ß-blocker.
Circulation: Cardiovascular Interventions, Ahead of Print. Discharging patients with NH-IMRangio<40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1–4] days per patient).CONCLUSIONS:NH-IMRangiois
Below are 6 anecdotal cases of true complete left main occlusion with no collateral circulation: 3 have STE in aVR 1 has no ST shift in aVR 2 have STD in aVR The ECG can have a variety of presentations in LM Occlusion. You'll see that there is collateral circulation from the RCA. Below is the angiogram. J Electrocardiol 2012;45:487-90.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
The Golden Hour post the Myocardial infarction (MI) It is a matter of great concern that 50% of individuals experiencing an acute heart attack pass away before reaching the hospital. This indicates that restoring normal blood circulation as quickly as possible will result in less damage. Perform rescue breaths twice.
The patient experienced cardiac arrest upon admission to a local hospital. Following cardiopulmonary resuscitation (CPR) and emergency femoral vascular reconstruction surgery, spontaneous circulation was temporarily restored, but the patient remained hemodynamically unstable postoperatively.
Whenever there is tachycardia, I am skeptical of OMI unless it has led to severely compromised ejection fracction with cardiogenicshock. Cardiology services were consulted at a PCI capable hospital. The green line in picture F shows contrast filling the PDA, representing left to right collateral circulation.
They can only be distinguished by: 1) if there are pulses, then it is not VF 2) if it spontaneously resolves, then it is not VF, with rare exceptions DOSE VF , New England Journal 2022 Remember that in the trial DOSE VF, pre-hospital use of DSED increased the likelihood of survival to hospital discharge by 17.1% in absolute terms!
1) as far as I can tell, there is very little data on amiodarone for this indication 2) amiodarone has beta blockade effects which could be deleterious in a patient with large anterior MI with pulmonary edema and at risk for cardiogenicshock (and she did go into shock. DOI: 10.1016/j.resuscitation.2025.110515
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content